Status:
COMPLETED
Norepinephrine Prophylaxis for Postspinal Anesthesia Hypotension
Lead Sponsor:
General Hospital of Ningxia Medical University
Conditions:
Adverse Effect
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the suitable infusion dose of norepinephrine for prophylaxis against post-spinal anesthesia hypotension.
Detailed Description
Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylacti...
Eligibility Criteria
Inclusion
- 18-40 years
- Primipara or multipara
- Singleton pregnancy ≥37 weeks
- American Society of Anesthesiologists physical status classification I to II
- Scheduled for elective cesarean section under spinal anesthesia
Exclusion
- Body height \< 150 cm
- Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
- Eclampsia or chronic hypertension or baseline blood pressure ≥ 160mmHg
- Hemoglobin \< 7g/dl
- Fetal distress, or known fetal developmental anomaly
Key Trial Info
Start Date :
March 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT04272567
Start Date
March 28 2020
End Date
June 30 2020
Last Update
August 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China, 750004